$LNZA

LanzaTech Global, Inc.

Insider trades
2
1
0

No SEC Form 4 filings for $LNZA in the last 30 days.

See all $LNZA insider activity →
Med

LanzaTech Global, Inc. Q2 2026 Earnings Call Summary

LanzaTech Global, Inc. reported Q2 2026 as a shift from R&D to project development and commercialization. Management said adjusted EBITDA improved after restructuring, including about $23M lower operating expenses YoY. 2026 guidance calls for $50M to $55M revenue and adjusted EBITDA loss of $22M to $26M. ISCC certification in China and EU could enable first certified ethanol sales in Q4.

LanzaTech Global, Inc.: LanzaTech Reports Second Quarter 2026 Financial Results

LanzaTech Global (NASDAQ: LNZA) reported Q2 2026 results for the quarter ended June 30, 2026. Revenue was $9.0 million, down 1% from $9.1 million. Operating expenses fell to $11.7 million (down 67% from $35.1 million). Net income was $184.3 million versus a $32.5 million loss, driven by a non-cash unrealized gain on its SGLT investment. Adjusted EBITDA improved to -$7.6 million. The company also advanced ISCC EU certification in China and selected North Sea Port Ghent for its FLITE SAF facility.

LanzaTech Global, Inc. (LNZA): Results of Operations and Financial Condition

LanzaTech Global, Inc. (LNZA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991lnzapressrelease_2q26.htm EX-99.1 Document LanzaTech Reports Second Quarter 2026 Financial Results Significant progress against cost reduction efforts positions business for sustained success LanzaTech advancing towards world's first ISCC EU certification for recyc

LNZA sentiment & insider activity

Over the past 7 days, alphai's AI scored 3 news stories mentioning LNZA (LanzaTech Global, Inc.). Coverage has skewed bullish: 2 bullish, 1 neutral, and 0 bearish.

Recent LNZA coverage spans financial news, earnings and corporate actions.

What's driving LNZA

  • Guidance and certification-driven sales timing (ISCC EU process completion triggering first certified ethanol sales in Q4) can shift near-term valuation expectations and risk appetite.

    yahoo.com · Aug 15, 2026

  • Cost reduction and certification progress improve the near-term commercialization narrative, but reported net income is heavily driven by a non-cash SGLT investment gain.

    finanznachrichten.de · Aug 14, 2026

  • Quarterly financials and operating updates suggest improving cost discipline and potential commercialization catalysts, but near-term fundamentals remain tied to project execution and equity-mark-to-market.

    SEC EDGAR 8-K · Aug 14, 2026

  • Routine shareholder-meeting outcomes; limited direct implications for near-term fundamentals beyond governance continuity.

    SEC EDGAR 8-K · Jun 24, 2026

  • HK IPO proceeds and disclosed JV ownership/asset base are likely supportive for LNZA sentiment, with near-term momentum already reflected in the stock’s surge.

    proactiveinvestors.com · Jun 4, 2026

alphai scores every news story that mentions LNZA with an AI model for sentiment and relevance, and aggregates insider trades from LanzaTech Global, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $LNZA

Score
$LNZAMed

LanzaTech Global, Inc. Q2 2026 Earnings Call Summary

LanzaTech Global, Inc. reported Q2 2026 as a shift from R&D to project development and commercialization. Management said adjusted EBITDA improved after restructuring, including about $23M lower operating expenses YoY. 2026 guidance calls for $50M to $55M revenue and adjusted EBITDA loss of $22M to $26M. ISCC certification in China and EU could enable first certified ethanol sales in Q4.

LanzaTech Global, Inc.: LanzaTech Reports Second Quarter 2026 Financial Results

LanzaTech Global (NASDAQ: LNZA) reported Q2 2026 results for the quarter ended June 30, 2026. Revenue was $9.0 million, down 1% from $9.1 million. Operating expenses fell to $11.7 million (down 67% from $35.1 million). Net income was $184.3 million versus a $32.5 million loss, driven by a non-cash unrealized gain on its SGLT investment. Adjusted EBITDA improved to -$7.6 million. The company also advanced ISCC EU certification in China and selected North Sea Port Ghent for its FLITE SAF facility.

$LNZAMed

LanzaTech Global, Inc. (LNZA): Results of Operations and Financial Condition

LanzaTech Global, Inc. (LNZA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991lnzapressrelease_2q26.htm EX-99.1 Document LanzaTech Reports Second Quarter 2026 Financial Results Significant progress against cost reduction efforts positions business for sustained success LanzaTech advancing towards world's first ISCC EU certification for recyc

$LNZALow

LanzaTech Global, Inc. (LNZA): Submission of Matters to a Vote of Security Holders

LanzaTech Global, Inc. (LNZA) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. amci-20260623 0001843724 false 0001843724 2026-06-23 2026-06-23 0001843724 us-gaap:CommonStockMember 2026-06-23 2026-06-23 0001843724 us-gaap:WarrantMember 2026-06-23 2026-06-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUA

$LNZAMedAI 8/10

LanzaTech JV raises about $75M in Hong Kong IPO

Beijing Shougang LanzaTech Technology Co., Ltd., a joint venture part-owned by LanzaTech Global (NASDAQ:LNZA), raised about $75M in gross proceeds via an IPO on the Hong Kong Stock Exchange, the company said. It sold 40M H-shares at about $1.86 each (code 02553). LanzaTech holds 33.52M H-shares (~8.38%). The JV runs four facilities and reported $77M–$87M annual revenue (2023–2025).

BRIGHT and LanzaTech Enter Multi-Year Agreement to Develop Next-Generation C1 Biofoundry for Carbon-to-Value Technologies

BRIGHT, a research institute at the Technical University of Denmark, and LanzaTech Global, Inc. have formed a multi-year partnership to advance carbon-to-value technologies. This collaboration, extending until April 2028, will establish a C1 biofoundry at DTU, combining LanzaTech's synthetic biology expertise with BRIGHT's facilities. The initiative aims to transform carbon emissions into valuable products through gas fermentation, accelerating sustainable innovation in Europe.

BRIGHT and LanzaTech launch new partnership to accelerate carbon-to-value biotechnology in Europe

BRIGHT, a research institute at DTU, and LanzaTech Global, Inc. have formed a multi-year partnership to advance carbon-to-value biotechnology in Europe. The collaboration involves establishing a next-generation C1 biofoundry at DTU to convert industrial carbon emissions into fuels, chemicals, and materials. This initiative aims to accelerate innovation in circular bioeconomy solutions and leverage LanzaTech's synthetic biology expertise with BRIGHT's infrastructure.

Related tickers